There is no cure for her.
Yet.
Sweet Baby Dior has an ultra-rare neurodegenerative mitochondrial disorder - less than 30 known cases worldwide.
Approved treatment for Trit-1 doesn't exist yet. The TECHNOLOGY to help her does.
But we are racing a cruel clock.
Gene Therapy is the most direct path to addressing the underlying cause.
Without treatment she may never walk or talk.
Without treatment, her brain must be numbed everyday to keep her alive. Everyday, seizures threaten to ravage her body. At their worst, doctors have had to shut down her brain, her breathing, and revive her just to break the cycle.
What we develop here, with your support, can light the way for other children - and even for other neurodegenerative diseases.
How Your Gift is Used This Year
This year your gifts fund the first essential scientific step: building a patient-specific mouse model of Dior’s TRIT-1 disorder.
Phase 1:
TRIT-1 Mouse Model (~$104,000).
Dr. Berge Minassian (UT Southwestern) and his team will use CRISPR gene editing to create mice that carry two copies of Dior’s TRIT-1 variant.
A viable model is the foundation everything else depends on. It is required before gene-replacement constructs can be properly tested and is the single highest-priority investment for this year.
What Happens Next
Once the model exists and is characterized, subsequent gifts will support:
- Design and laboratory production of a TRIT-1 gene-therapy construct
- Testing of that construct in the patient-derived model - Preparation of the data package needed for larger-scale work
All funds raised through this page are held by Rare Village Foundation (EIN 83-4699994) in the dedicated Cure Trit-1 fund and are used solely for TRIT-1 research and related program costs.
